AU1392801A - Casb7434, an antigen over-expressed in colon cancer - Google Patents

Casb7434, an antigen over-expressed in colon cancer

Info

Publication number
AU1392801A
AU1392801A AU13928/01A AU1392801A AU1392801A AU 1392801 A AU1392801 A AU 1392801A AU 13928/01 A AU13928/01 A AU 13928/01A AU 1392801 A AU1392801 A AU 1392801A AU 1392801 A AU1392801 A AU 1392801A
Authority
AU
Australia
Prior art keywords
casb7434
expressed
colon cancer
antigen over
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13928/01A
Inventor
Jean-Pol Cassart
Thierry Coche
Swann Roman Jean-Thomas Gaulis
Carlota Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926636.3A external-priority patent/GB9926636D0/en
Priority claimed from GB0008809A external-priority patent/GB0008809D0/en
Priority claimed from GB0012703A external-priority patent/GB0012703D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU1392801A publication Critical patent/AU1392801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU13928/01A 1999-11-10 2000-11-06 Casb7434, an antigen over-expressed in colon cancer Abandoned AU1392801A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9926636 1999-11-10
GBGB9926636.3A GB9926636D0 (en) 1999-11-11 1999-11-11 Novel compounds
GB0008809 2000-04-10
GB0008809A GB0008809D0 (en) 2000-04-10 2000-04-10 Novel compounds
GB0012703 2000-05-24
GB0012703A GB0012703D0 (en) 2000-05-24 2000-05-24 Novel compounds
PCT/EP2000/010979 WO2001034794A1 (en) 1999-11-10 2000-11-06 Casb7434, an antigen over-expressed in colon cancer

Publications (1)

Publication Number Publication Date
AU1392801A true AU1392801A (en) 2001-06-06

Family

ID=27255661

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13928/01A Abandoned AU1392801A (en) 1999-11-10 2000-11-06 Casb7434, an antigen over-expressed in colon cancer

Country Status (2)

Country Link
AU (1) AU1392801A (en)
WO (1) WO2001034794A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139356A1 (en) 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
CN1606446A (en) 2000-05-19 2005-04-13 科里克萨有限公司 Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides
WO2006114478A1 (en) * 2005-04-26 2006-11-02 Karyon-Ctt Ltd Diagnostic and therapeutic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000084A4 (en) * 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 human secreted proteins
GB9806164D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
WO2001034794A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU5047800A (en) Breast, gastric and prostate cancer associated antigens and uses therefor
AU2001229682A1 (en) Small cell lung cancer associated antigens and uses therefor
AU2002212527A1 (en) Thermometry-based breast cancer risk assessment
AU2002210751A1 (en) Transaction authentication
AUPR395801A0 (en) Antibodies against cancer
AU3546400A (en) Tandem immuno-assay for cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU1922301A (en) Differential gene expression in cancer
AU2001290860A1 (en) Spas-1 cancer antigen
AU1887900A (en) Marked, difficult-to-counterfeit documents
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
AU6278300A (en) Tumor-associated antigen (r11)
AU2948199A (en) Breast cancer antigen
AU2003203140A1 (en) Immunogenic carcinoembryonic antigen (cea)
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU8026300A (en) Sodd gene expression in cancer
AU3283500A (en) Tumor-associated antigen
ZA200001529B (en) Coin-receiving device.
AU1392801A (en) Casb7434, an antigen over-expressed in colon cancer
AU2003219696A1 (en) Sga-1m, a cancer associated antigen, and uses thereof
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
HUP0202270A3 (en) Antitumor antibodies, proteins, and uses thereof
AU3416599A (en) Casb414: antigen overexpressed in several tumors
AU5632500A (en) Cancer associated antigens and uses therefor
AU4553100A (en) Tumour-associated antigen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 36, PAGE(S) 7808-7811 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 44276/00, 61751/00, 76984/00, 10413/01, 11280/01, 11545/01, 11657/01, 11680/01, 11717/01, 12665/01, 12881/01, 12892/01, 12898/01, 12911/01, 12916/01, 12958/01, 13149/01, 13715/01, 13788/01, 13928/01, 14014/01, 14030/01, 14043/01, 15162/01, 15204/01, 15284/01, 15430/01, 17116/01, 17119/01, 17128/01, 18572/01, 18837/01, 18840/01, 18842/01, 18852/01, 18854/01, 19018/01, 19973/01, 19988/01, 20137/01, 20141/01, 20143/01, 21499/01, 21567/01, 22362/01, 22363/01, 24211/01, 24817/01 AND 26677/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase